Juan P. Alderuccio, Md
Clinical trials sponsored by Juan P. Alderuccio, Md, explained in plain language.
-
New drug cocktail targets brain lymphoma in early trial
Disease control Recruiting nowThis early-phase study tests a combination of drugs (zanubrutinib, Pola-R-CHP, and high-dose methotrexate) in 20 adults with large B-cell lymphoma that has spread to the brain or spinal cord. The main goal is to check for side effects and find safe doses. Researchers will also tr…
Phase: PHASE1 • Sponsor: Juan P. Alderuccio, MD • Aim: Disease control
Last updated May 17, 2026 08:13 UTC
-
New drug combo aims to beat back tough lymphoma
Disease control Recruiting nowThis study tests whether a combination of two drugs, loncastuximab tesirine and rituximab, can make follicular lymphoma disappear completely in people whose cancer has returned or not responded to prior therapy. About 100 adults with this type of lymphoma will receive the treatme…
Phase: PHASE2 • Sponsor: Juan P. Alderuccio, MD • Aim: Disease control
Last updated May 17, 2026 08:04 UTC